Literature DB >> 16304220

Surgery for non-small cell carcinoma in geriatric patients: 15-year experience.

Horia Sirbu1, Waldemar Schreiner, Harald Dalichau, Thomas Busch.   

Abstract

The purpose of this study was to determine the clinical patterns, short- and long-term survival in elderly patients after surgery for non-small cell lung carcinoma. The 273 patients aged over 70 years who underwent curative resection from 1986 to 2001 were retrospectively assessed. Mean age was 73.2+/-3.1 years, (11% were>80 years). The mean follow-up was 31 months. Standard procedures were used: 151 lobectomies, 49 bilateral lobectomies, 42 pneumonectomies, 9 sleeve resections, and 22 wedge resections. The 30-day mortality was 5.4%. Multivariate analysis showed that extended procedures, male sex, and age were predictors of mortality. Overall survival rates at 5, 10, and 15 years were 35.6%, 10.5%, and 2.5%, respectively. Advanced disease stage, low forced expiratory volume in 1 second, and previous cardiac disease were independent predictors that adversely influenced survival. Geriatric patients with non-small cell lung carcinoma can undergo resection safely with acceptable long-term survival. Lobectomy is the procedure of choice, extended resections should only be carried out in highly selected patients. Careful attention to preoperative clinical staging is important as the elderly beyond the early stage of disease fare poorly. Surgery is justified for the treatment of stage I-II lung cancer.

Entities:  

Mesh:

Year:  2005        PMID: 16304220     DOI: 10.1177/021849230501300408

Source DB:  PubMed          Journal:  Asian Cardiovasc Thorac Ann        ISSN: 0218-4923


  2 in total

1.  A model for morbidity after lung resection in octogenarians.

Authors:  Mark F Berry; Mark W Onaitis; Betty C Tong; David H Harpole; Thomas A D'Amico
Journal:  Eur J Cardiothorac Surg       Date:  2011-01-26       Impact factor: 4.191

2.  Pneumonectomy for lung cancer in the elderly: lessons learned from a multicenter study.

Authors:  Fabrizio Minervini; Gregor J Kocher; Pietro Bertoglio; Peter B Kestenholz; Carlos Gálvez Muñoz; Davide Patrini; Laurens J Ceulemans; Housne Begum; Jon Lutz; Max Shojai; Yaron Shargall; Marco Scarci
Journal:  J Thorac Dis       Date:  2021-10       Impact factor: 2.895

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.